Aarti Drugs lines up Oriental push

 The company is in advance stages of developing 12 new molecules to be commercialised shortly and has filed for Certificate of Suitability (COS) for 6 products for the European markets.

 In a strategic move, ADL has decided to increase its focus on Chinese and Japanese markets. Apart from exports to China, ADL is hunting for manufacturing facilities there for exports as well as to serve the local Chinese market.